Last quarter (Q2 2023), Eagle Pharmaceuticals's total revenue was $64.65M, a decrease of -12.80% from the same quarter last year. In Q2, Eagle Pharmaceuticals's net income was $5.16M. See Eagle Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 237.47M	$ 316.61M	$ 171.55M	$ 187.80M	$ 195.89M	$ 213.31M
Cost of Revenue	$ 4.97M	$ 85.46M	$ -31.53M	$ 45.47M	$ 60.90M	$ 61.92M
Gross Profit	$ 216.10M	$ 231.15M	$ 140.02M	$ 142.34M	$ 135.00M	$ 151.40M
Operating Expense	$ 66.03M	$ 150.19M	$ 137.25M	$ 109.38M	$ 113.18M	$ 104.93M
Operating Income	$ 150.07M	$ 80.96M	$ 2.77M	$ 32.95M	$ 21.82M	$ 46.47M
Net Non Operating Interest Income Expense	$ -5.81M	$ -3.77M	$ -1.07M	$ -2.02M	$ -517.00K	$ -2.58M
Other Income Expense	$ -17.04M	$ 15.75M	$ 6.24M	$ -8.26M	$ 700.00K	$ -9.85M
Pretax Income	$ 29.17M	$ 61.43M	$ -4.55M	$ 22.68M	$ 22.00M	$ 34.04M
Tax Provision	$ 17.22M	$ 25.79M	$ 4.08M	$ 10.69M	$ 7.68M	$ 2.13M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 121.01M	$ 35.64M	$ -8.63M	$ 11.99M	$ 14.31M	$ 31.90M
Basic EPS	$ 0.86	$ 2.76	$ -0.66	$ 0.89	$ 1.04	$ 2.16
Diluted EPS	$ 0.89	$ 2.73	$ -0.66	$ 0.87	$ 1.01	$ 2.09
Basic Average Shares	$ 52.25M	$ 12.93M	$ 13.05M	$ 13.48M	$ 13.75M	$ 14.77M
Diluted Average Shares	$ 52.54M	$ 13.07M	$ 13.05M	$ 13.77M	$ 14.14M	$ 15.28M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ 1.13	-	-	-	$ 2.68	$ 4.01
Reported Normalized Diluted E P S	$ 1.12	-	-	-	$ 2.61	$ 3.87
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 71.00M	$ 235.65M	$ 105.72M	$ 154.85M	$ 174.08M	$ 166.84M
Net Income From Continuing And Discontinued Operation	$ 11.95M	$ 35.64M	$ -8.63M	$ 11.99M	$ 14.31M	$ 31.90M
Normalized Income	$ 214.42K	$ 48.53M	-	$ 11.99M	$ 14.31M	$ 41.16M
Interest Expense	$ 1.59M	-	-	$ 2.58M	$ 2.69M	$ 2.74M
EBIT	$ 35.39M	$ 65.48M	$ -2.91M	$ 25.25M	$ 24.68M	$ 36.77M
EBITDA	$ 58.05M	$ 79.24M	$ 2.37M	$ 28.79M	$ 29.34M	$ 40.44M

Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing